Marrazzi & Hart (1955). Relationship of hallucinogens to adrenergic cerebral neurohumors. Science.
Malitz et al. (1960). Some observations on psilocybin, a new hallucinogen, in volunteer subjects. Comprehensive Psychiatry.
Esecover (1961). Clinical profiles of paid normal subjects volunteering for hallucinogen drug studies. The American Journal of Psychiatry.
Wilkens, Malitz & Esecover (1962). Clinical observations of simultaneous hallucinogen administration in identical twins. The American Journal of Psychiatry.
Harman (1963). Some aspects of the psychedelic-drug controversy. Journal of Humanistic Psychology.
Jacobsen (1963). The clinical pharmacology of the hallucinogens. Clinical Pharmacology & Therapeutics.
Alnaes (1964). Therapeutic application of the change in consciousness produced by psycholytica (LSD, psilocybin, etc.). the psychedelic experience in the treatment of neurosis. Acta Psychiatrica Scandinavica.
Hanley (1964). Psychedelics (hallucinogens). Canadian Medical Association Journal.
Mogar & Savage (1964). Personality change associated with psychedelic (LSD) therapy: A preliminary report. Psychotherapy: Theory, Research & Practice.
Savage et al. (1964). LSD: therapeutic effects of the psychedelic experience. Psychological Reports.
Fadiman (1965). Genista canariensis: A minor psychedelic. Economic Botany.
Mogar (1965). Current status and future trends in psychedelic (LSD) research. Journal of Humanistic Psychology.
Harman et al. (1966). Psychedelic agents in creative problem-solving: A pilot study. Psychological Reports.
Rinkel (1966). Psychedelic drugs. The American Journal of Psychiatry.
Buck (1967). Psychedelic effect of Pholiota spectabilis. The New England Journal of Medicine.
Clark (1967). Religious aspects of the psychedelic substances and the law. International Journal of Parapsychology.
Clarke (1967). The Identification of some proscribed psychedelic drugs. Journal of the Forensic Science Society.
Klavetter & Mogar (1967). Peak Experiences: Investigation of their relationship to psychedelic therapy and self-actualization. Journal of Humanistic Psychology.
Kurland et al. (1967). Psychedelic therapy utilizing LSD in the treatment of the alcoholic patient: a preliminary report. The American Journal of Psychiatry.
Muller (1967). Unpublicized hallucinogens: The dangerous belladonna alkaloids. JAMA.
Robbins et al. (1967). Implications of untoward reactions to hallucinogens. Bulletin of the New York Academy of Medicine.
Rubin (1967). Do it yourself hallucinogens. JAMA.
Brickman (1968). The psychedelic "hip scene": return of the death instinct. The American Journal of Psychiatry.
Brown (1968). Stramonium and Belladonna hallucinogens. JAMA.
Clark (1968). Religious aspects of psychedelic drugs. California Law Review.
Cohen (1968). The cyclic psychedelics. The American Journal of Psychiatry.
Dobkin (1968). Folk curing with a psychedelic cactus in the north coast of Peru. The International Journal of Social Psychiatry.
Freedman (1968). The use and abuse of psychedelic drugs. Bulletin of the Atomic Scientists.
Genest & Hughes (1968). Chromatographic methods for the identification of the new hallucinogen, 4-methyl-2,5-dimethoxy-α-methyl-phenethylamine, and related drugs. The Analyst.
Kraines (1968). The hallucinogens. JAMA.
Krippner (1968). The psychedelic state, the hypnotic trance, and the creative act. Journal of Humanistic Psychology.
Lekisch (1968). Understanding the psychedelic craze. Canadian Family Physician.
Schachter (1968). Psychedelic drug use by adolescents. Social Work.
Schneider (1968). Behavioural effects of some morphine antagonists and hallucinogens in the rat.
Smythies (1968). Hallucinogens. Nature.
Snyder & Richelson (1968). Psychedelic drugs: steric factors that predict psychotropic activity. PNAS.
Tart (1968). Ethics and psychedelic drugs. American Psychologist.
Watts (1968). Psychedelics and religious experience. California Law Review.
Edwards, Bloom & Cohen (1969). The psychedelics: Love or hostility potion? Psychological Reports.
Halasz, Formanek & Marrazzi (1969). Hallucinogen-tranquilizer interaction: Its nature. Science.
Lancet (1969). New ways with hallucinogens. The Lancet.
Schultes (1969). Hallucinogens of plant origin. Science.
Siegel & Poole (1969). Psychedelic-induced social behavior in mice: A preliminary report. Psychological Reports.
Abramson (1970). Psychedelic drugs. JAMA.
Cheek (1970). Paul's mysticism in the light of psychedelic experience. Journal of the American Academy of Religion.
Dorrance, Janiger & Teplitz (1970). In vivo effects of illicit hallucinogens on human lymphocyte chromosomes. JAMA.
Hart (1970). The Zen of Hubert Benoit. Journal of Transpersonal Psychology.
Klavetter et al. (1970). Changes on the Myers-Briggs following psychedelic therapy: A pilot study. Psychological Reports.
Pahnke et al. (1970). The experimental use of psychedelic (LSD) psychotherapy. JAMA.
Prance (1970). Notes on the use of plant hallucinogens in Amazonian Brazil. Economic Botany.
Weech & Bibb (1970). Toward a rational approach to psychedelics: The controversy over popular use from a clinical viewpoint. Comprehensive Psychiatry.
Di Cyan (1971). Poetry and creativeness with notes on the role of psychedelic agents. Perspectives in Biology and Medicine.
Donlon (1971). The psychedelic plague and polypsychotropia. JAMA.
Gilbert (1971). Pseudo mind-expansion through psychedelics and brain-wave-programming versus true mind-expansion through life conditioning to the absolute. Psychologia: An International Journal of Psychology in the Orient.
Katz (1971). Review of psychedelics: The uses and implications of hallucinogenic drugs. Contemporary Psychology.
Meek & Fuxe (1971). Serotonin accumulation after monoamine oxidase inhibition: Effects of decreased impulse flow and of some anti-depressants and hallucinogens. Biochemical Pharmacology.
Pittel et al. (1971). Developmental factors in adolescent drug use: A study of psychedelic drug users. Journal of the American Academy of Child Psychiatry.
Razdan & Sheehan (1971). Chapter 3. Hallucinogens. Annual Reports in Medicinal Chemistry.
Siegel (1971). Towards a psychology of psychedelics and population behavior. Journal of Psychedelic Drugs.
Taylor (1971). History and pharmacology of psychedelic drugs. International Journal of Clinical Pharmacology, Therapy & Toxicology.
Tonge & Leonard (1971). Hallucinogens and non-hallucinogens: A comparison of the effects on 5-hydroxytryptamine and noradrenaline. Life Sciences.
Barber (1972). Psychedelic drugs and anesthesia. California Medicine.
Brawley & Duffield (1972). The pharmacology of hallucinogens. Pharmacological Reviews.
Chunko (1972). The psychedelic experience: High adolescence. Journal of Drug Education.
Duncan (1972). Psychedelic drugs in correctional treatment. Crime & Delinquency.
Levi (1972). Psychedelic science. Journal of Aesthetic Education.
Ludwig (1972). "Psychedelic" effects produced by sensory overload. The American journal of Psychiatry.
McGlothlin (1972). Psychedelics warmed over. Contemporary Psychology.
Pittel & Hofer (1972). The transition to amphetamine abuse. Journal of Psychedelic Drugs.
Aaron, Sanders & Winefordner (1973). Analytical study of some important hallucinogens by a combined fluorimetric and phosphorimetric method. Clinica Chimica Acta.
Dyer & Gant (1973). Vasoconstriction produced by hallucinogens on isolated human and sheep umbilical vasculature. The Journal of Pharmacology and Experimental Therapeutics.
Fabrick & Winefordner (1973). Quantitative measurement of mixtures of hallucinogens by fluorometry and phosphorimetry. Talanta.
Gay & Sheppard (1973). "Sex-crazed dope fiends": Myth or reality? Drug Forum.
Glass (1973). Psychedelic drugs, stress, and the ego. The differential diagnosis of psychosis associated with psychotomimetic drug use. The Journal of Nervous and Mental Disease.
Heacock & Forrest (1973). The use of electron-acceptor reagents for the detection of some hallucinogens. Journal of Chromatography.
Kaiser & Gold (1973). Perception, psychedelics, and social change. Journal of Drug Education.
Atkyns & Hanneman (1974). Illicit drug distribution and dealer communication behavior. Journal of Health and Social Behavior.
Matefy & Krall (1974). An initial investigation of the psychedelic drug flashback phenomena. Journal of Consulting and Clinical Psychology.
Mccabe (1974). Psychedelic (LSD) psychotherapy: A case report. Psychotherapy: Theory, Research & Practice.
Sinnett et al. (1974). Sensitivity of the experiential world inventory to psychedelic drug states. Psychological Reports.
Snyder et al. (1974). Drugs, neurotransmitters, and schizophrenia. Science.
Wesson, Smith & Linda (1974). Drug crisis intervention: Conceptual and pragmatic considerations. Journal of Psychedelic Drugs.
Ayd (1975). Psychedelic drugs. JAMA.
Clark, Lieff & Sussman (1975). Psychedelic research: Obstacles and values. Journal of Humanistic Psychology.
di Leo (1975). The use of psychedelics in psychotherapy. Journal of Altered States of Consciousness.
Garfield (1975). Consciousness alteration and fear of death. Journal of Transpersonal Psychology.
Heaton (1975). Subject expectancy and environmental factors as determinants of psychedelic flashback experiences. The Journal of Nervous and Mental Disease.
Hirschhorn & Winter (1975). Differences in the stimulus properties of barbital and hallucinogens. Pharmacology, Biochemistry, and Behavior.
Matefy & Krall (1975). Psychedelic drug flashbacks: psychotic manifestation or imaginative role playing? Journal of Consulting and Clinical Psychology.
Silverman (1975). On the effects and uses of psychedelic drugs. Journal of Altered States of Consciousness.
Zinberg, Jacobson & Harding (1975). Social sanctions and rituals as a basis for drug abuse prevention. The American Journal of Drug and Alcohol Abuse.
Gillin et al. (1976). The psychedelic model of schizophrenia: the case of N,N-dimethyltryptamine. The American Journal of Psychiatry.
Heaton & Victor (1976). Personality characteristics associated with psychedelic flashbacks in natural and experimental settings. Journal of Abnormal Psychology.